Eye Health New E-Book Initiative from AstaReal
AstaReal has published a new e-book exploring how eye health has evolved globally as screen usage continues to increase.
“The e-book summarizes current research on how nutrition and natural astaxanthin may help support vision in an increasingly digital everyday life. We are seeing growing global interest in eye health, particularly linked to increasing screen use among both children and adults,” says Behnaz Shakersain, Scientific Affairs Manager at AstaReal AB.
The e-book, Astaxanthin and the Evolution of Vision Care in a Screen-Centric World, describes how high screen time, reduced outdoor activity, and an ageing population are affecting vision health worldwide. It also highlights research on ocular nutrition and how different nutrients, including astaxanthin, may help support eye function.
The book also explores research related to digital eye strain, or Computer Vision Syndrome, a growing issue associated with prolonged screen use. Among the studies highlighted is the 2025 study in which children aged 10 to 14 showed reduced eye fatigue and improved stereoscopic vision after daily intake of AstaReal’s natural astaxanthin.
“Research on eye health in general, and digital eye strain in particular, has developed rapidly in recent years. At the same time, we see a growing need for more knowledge about how today’s screen use affects younger generations and the role preventive approaches may play going forward.”
The e-book also covers topics such as myopia, presbyopia, oxidative stress, and age-related vision changes, while describing how the global eye health market is evolving and how astaxanthin is gaining an increasingly prominent position.
“Interest in vision nutrition is growing rapidly, both in research and product development. By bringing together science, market trends, and clinical data, we want to contribute to a more science-based approach to the future of eye health,” says Behnaz Shakersain, Scientific Affairs Manager at AstaReal AB.
The new e-book was developed as a joint initiative by AstaReal’s global science team, bringing together researchers and experts from multiple regions, and is available for download here
For more information, please contact:
Edwin Eriksson, Press Contact, +46 (0)73 975 79 19, edwin.eriksson@greatness.se
Peter Ahlm, Head of Marketing & Sales, +46 (0)73 868 48 39, peter.ahlm@astareal.se
AstaReal AB is a global leader in the production and research of natural antioxidant astaxanthin, with clinically proven solutions to enhance health and well-being. With origins in Uppsala University, Sweden, AstaReal was first to commercially produce natural astaxanthin and introduced the Astaxin supplement in 1995. The company supplies natural astaxanthin to supplement manufacturers and produces its own brand products. AstaReal is part of the AstaReal Group, fully owned by Fuji Chemical Industries Co., Ltd., with its European headquarters in Stockholm. Read more at www.astareal.se
